de Souza Paulo César Fernandes, Espinosa Mariano Martinez, Teixeira Maria Teresa Bustamante, de Lima Fernanda Cristina da Silva, Galvão Noemi Dreyer
Instituto de Salud Colectiva de la Universidad Federal de Mato Grosso, Cuiabá, Mato Grosso 78060-900, Brasil.
Departamento de Salud del Estado de Mato Grosso, Cuiabá, Mato Grosso 78049-902, Brasil.
Ecancermedicalscience. 2024 Sep 12;18:1764. doi: 10.3332/ecancer.2024.1764. eCollection 2024.
To estimate the survival patterns of childhood leukaemias and lymphomas in Mato Grosso between 2001 and 2017.
Retrospective population-based cohort study, with case information extracted from the population-based cancer registries (PBCRs) of Mato Grosso for the period 2001-2017. Cases aged 0-19 years diagnosed with microscopically confirmed leukaemias or lymphomas were eligible. Five-year relative survival was calculated using the Eldererer II method, considering the interval between diagnosis and death, loss to follow-up or censoring, after passive follow-up in the mortality information system. Cases registered only by death certificate were excluded.
510 cases of leukaemia were analysed, with a predominance of males (56.1%) and an age range of 0-4 years (34.9%). The 5-year relative survival rate was 77.3% (95% CI: 73.6;80.9). As for lymphomas, there were 261 cases, predominantly in males and in the age group 5-9 years. The 5-year relative survival rate was 84.7% (95% CI: 78.3;88.9), with a better prognosis for females and 87.7% (95% CI: 80.8;95.1) in the 5-9 years age group.
The relative survival rates of childhood leukaemia and lymphoma in the state of Mato Grosso were lower than those of developed countries. The importance of early diagnosis and timely treatment for better outcomes is highlighted. The importance of using and continuously improving the quality of information from PBCRs in the state of Mato Grosso is highlighted.
评估2001年至2017年间马托格罗索州儿童白血病和淋巴瘤的生存模式。
基于人群的回顾性队列研究,病例信息从马托格罗索州2001 - 2017年基于人群的癌症登记处(PBCRs)中提取。年龄在0 - 19岁、经显微镜确诊为白血病或淋巴瘤的病例符合条件。在死亡率信息系统进行被动随访后,采用Eldererer II方法计算五年相对生存率,同时考虑诊断与死亡之间的间隔、失访或截尾情况。仅通过死亡证明登记的病例被排除。
分析了510例白血病病例,男性占主导(56.1%),年龄范围为0 - 4岁(34.9%)。五年相对生存率为77.3%(95%置信区间:73.6;80.9)。至于淋巴瘤,有261例,主要为男性,年龄组为5 - 9岁。五年相对生存率为84.7%(95%置信区间:78.3;88.9),女性预后较好,5 - 9岁年龄组为87.7%(95%置信区间:80.8;95.1)。
马托格罗索州儿童白血病和淋巴瘤的相对生存率低于发达国家。强调了早期诊断和及时治疗以获得更好预后的重要性。强调了使用和持续提高马托格罗索州PBCRs信息质量的重要性。